Lichen depsidones as potential novel pharmacologically active compounds

Mini-Reviews in Organic Chemistry

Volumn 9, Issue 2, 2012, Pages 178-184

  Stojanović, Gordana ^a   Stojanović, Igor ^a   Šmelcerović, Andrija ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Biological activity; Biosynthesis; Depsidones; Lichen; Structure activity relationship

Indexed keywords

EID: 84861156273     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019312800604689     Document Type: Review

References (54)

1. Molnar, K.; Farkas, E. Current results on biological activities of lichen secondary metabolites: a review. Z. Naturforsch., 2010, 65c, 157-173.
2. Yuan, X.; Xiao, S.; Taylor, T.N. Lichen-like symbiosis 600 million years ago. Science, 2005, 308, 1017-1020.
3. Huneck, S. The significance of lichens and their metabolites. Naturwissenschaften, 1999, 86(12), 559-570.
4. Upreti, D.K.; Divakar, P.K.; Nayaka, S. Commercial and ethnic use of lichens in India. Econ. Bot., 2005, 59(3), 269-273.
5. Gupta, V.K.; Darokar, M.P.; Saikia, D.; Pal, A.; Fatima, A.; Khanuja, S.P.S. Antimycobacterial activity of lichens. Pharm. Biol., 2007, 45(3), 200-204.
6. Muller, K. Pharmaceutically relevant metabolites from lichens. Appl. Microbiol. Biotechnol., 2001, 56, 9-16.
7. Stocker-Wörgötter, E. Metabolic diversity of lichen-forming ascomycetous fungi: culturing, polyketide and shikimate metabolite production, and PKS genes. Nat. Prod. Rep., 2008, 25(1), 188-200.
8. Yamamoto, Y.; Kinoshita, Y.; Matsubara, H.; Kinoshita, K.; Koyama, K.; Takahashi, K.; Kurokawa, T.; Yoshimura, I. Screening of biological activities and isolation of biological active compounds from lichens. Recent Res. Dev. Phytochem., 1998, 2, 23-24.
9. Romagni, J.G.; Dayan F.E. Structural diversity of lichen metabolites and their potential use. In: Advances in Microbial Toxin Research and its Biotechnological Exploitation; Upadhyay R.K., Ed.; Kluwer Academic/Plenum Publishers: New York, 2002; pp.151-169.
10. Boustie, J.; Grube, M. Lichens, a promising source of bioactive secondary metabolites. Plant Genet. Resour., 2005, 3, 273-287.
11. Takahashi, K.; Kinoshita, K.; Yamamoto, Y.; Yoshimura, I. Chemical constituents from lichens for pharmaceutical and industrial uses. Folia Cryptogam Est., 2005, 41, 109-114.
12. Podterob, A.P. Chemical composition of lichens and their medical application. Pharm. Chem. J., 2008, 42, 582-588.
13. Muggia, L.; Schmitt, I.; Grube, M. Lichens as treasure chests of natural products. Sim News, 2009, 59, 85-97.
14. Shukla, V.; Pant Joshi, G.; Rawat, M.S.M. Lichens as a potential natural source of bioactive compounds: a review. Phytochem. Rev., 2010, 9(2), 303-314.
15. Boustie, J.; Tomasi, S.; Grube, M. Bioactive lichen metabolites: alpine habitats as an untapped source, Phytochem. Rev., DOI 10.1007/s11101-010-9201-1.
16. Bezivin, C.; Tomasi, S.; Lohezic-Le Devehat, F.; Boustie J. Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomedicine, 2003, 10, 49503.
17. Turk, A.O.; Yilmaz, M.; Kivanc, M.; Turk H. The antimicrobial activity of extracts of the lichen Cetraria aculeata and its protolichesterinic acid constituent. Z. Naturforsch., 2003, 58c, 850-854.
18. Halama, P.; Van Haluwin, C. Antifungal activity of lichen extracts and lichenic acids. BioControl, 2004, 49, 95-107.
19. Odabasoglu, F.; Aslan, A.; Cakir, A.; Suleyman, H.; Karagoz, Y.; Halici, M.; Bayir Y. Comparison of antioxidant activity and phenolic content of three lichen species. Phytother. Res., 2004, 18, 938-941.
20. Rankoviš, B.; Mišiš, M. Antifungal activity of extracts of the lichens Alectoria sarmentosa and Cladonia rangiferina. Mikol. Fitopatol., 2007, 41, 276-281.
21. Schmeda-Hirschmann, G.; Tapia, A.; Lima, B.; Pertino, M.; Sortino, M.; Zacchino, S.; Rojas De Arias, A.; Feresin, G.E. A new antifungal and antiprotozoal depside from the Andean lichen Protousnea poeppigii. Phytother. Res., 2008, 22, 349-355.
22. Esimone, C.O.; Grunwald, T.; Nworu, C.S.; Kuate, S.; Proksch, P.; Uberla, K. Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach. Chemotherapy, 2009, 55, 119-126.
23. Karakus, B.; Odabasoglu, F.; Cakir, A.; Halici, Z.; Bayir, Y.; Halici, M.; Aslan, A.; Suleyman, H. The effects of methanol extract of Lobaria pulmonaria, a lichen species, on indometacin-induced gastric mucosal damage, oxidative stress and neutrophil infiltration. Phytother. Res., 2009, 23, 635-639.
24. Stojanoviš, G.; Stojanoviš, I.; Stankov-Jovanoviš, V.; Mitiš, V.; Kostiš, D. Reducing power and radical scavenging activity of four Parmeliaceae species. Cent. Eur. J. Biol., 2010, 5(6), 808-813.
25. Hamano, K.; Kinoshita-Okami, M.; Hemmi, A.; Sato, A.; Hisamoto, M.; Matsuda, K.; Yoda, K.; Haruyama, H.; Hosoya, T.; Tanzawa, K. Folipastatin, a new depsidone compound from Aspergillus unguis as an inhibitor of phospholipase A2: taxonomy, fermentation, isolation, structure determination and biological properties. J. Antibiot., 1992, 45(8), 1195-1201.
26. Stark, A.A.; Kobbe, B.; Matsuo, D.; Buchi, G.; Wogan, G.N.; Demain, A.L. Mollicellins: mutagenic and antibacterial mycotoxins. Appl. Environ. Microbiol., 1978, 36, 412-420.
27. Abdou, R.; Scherlach, K.; Dahse, H.M.; Sattler, I.; Hertweck, C. Botryorhodines A-D, antifungal and cytotoxic depsidones from Botryosphaeria rhodina, an endophyte of the medicinal plant Bidens pilosa. Phytochemistry, 2009, 71(1), 110-116.
28. Chomcheon, P.; Wiyakrutta, S.; Sriubolmas, N.; Ngamrojanavanich, N.; Kengtong, S.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Aromatase inhibitory, radical scavenging, and antioxidant activities of depsidones and diaryl ethers from the endophytic fungus Corynespora cassiicola L36. Phytochemistry, 2009, 70(3), 407-413.
29. Permana, D.; Abas, F.; Maulidiani, S.; Khozirah, S.; Johnson, A.; Abdul Manaf, L.; Nordin, Hj. Atrovirisidone B, a new prenylated depsidone with cytotoxic property from the roots of Garcinia atroviridis. Z. Naturforsch., 2005, 60c(7/8), 523-526.
30. Xu, Y.J.; Chiang, P.Y.; Lai, Y.H.; Vittal, J.J.; Wu, X.H.; Tan, B.K.H.; Imiyabir, Z.; Goh, S.H. Cytotoxic prenylated depsidones from Garcinia parvifolia. J. Nat. Prod., 2000, 63(10), 1361-1363.
31. Ngoupayo, J.; Tabopda, T. K.; Ali, M. S.; Tsamo, E. α-Glucosidase inhibitors from Garcinia brevipedicellata (Clusiaceae). Chem. Pharm. Bull., 2008, 56(10), 1466-1469.
32. Ito, C.; Itoigawa, M.; Mishina, Y.; Tomiyasu, H.; Litaudon, M.; Cosson, J.P.; Mukainaka, T.; Tokuda, H.; Nishino, H.; Furukawa, H. Cancer chemopreventive agents. New depsidones from Garcinia plants. J. Nat. Prod., 2001, 64(2), 147-150.
33. Sala, T.; Sargent, M.V. Depsidone synthesis. Part 16. Benzophenone-grisa- 3',5'-diene-2',3-dione-depsidone interconversion: a new theory of depsidone biosynthesis. J. Chem. Soc., Perkin Trans. 1, 1981, 855-869.
34. Elix, J.A.; Jenie, U.A.; Parker, J.L. A novel synthesis of the lichen depsidones divaronic acid and stenosporonic acid, and the biosynthetic implications. Aust. J. Chem., 1987, 40(8), 1451-1464.
35. Ogmundsdottir, H.M.; Zoega, G.M.; Gissurarson, S.R.; Ingolfsdottir, K. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogenstimulated lymphocytes. J. Pharm. Pharmacol., 1998, 50, 107-115.
36. Correché, E.R.; Carrasco, M. Cytotoxic screening activity of secondary lichen metabolites. Acta Farm. Bonaerense, 2002, 21, 273-278.
37. Haralsdottir, S.; Guolaugsdottir, E.; Ingolfsdottir, K.; Ogmundsdóttir, H.M. Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro. Planta Med., 2004, 70, 1098-1110.
38. Russo, A.; Piovano, M.; Lombardo, L. Vanella, L.; Cardile, V.; Garbarino, J. Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Anti-Cancer Drugs, 2006, 17, 1163-1169.
39. Millot, M.; Tomasi, S.; Articus, K.; Rouaud, I.; Bernard, A.; Boustie, J. Metabolites from the lichen Ochrolechia parella growing under two different heliotropic conditions. J. Nat. Prod., 2007, 70(2), 316-318.
40. Russo, A.; Piovano, M.; Lombardo, L.; Cardile, V. Lichen metabolites prevent UV light and nitric-oxide mediated plasmid DNA damage and induce apoptosis in human melanoma cells. Life Sci., 2008, 83, 468-474.
41. Micheletti, A.C.; Beatriz, A.; Pires de Lima, D.; Honda, N.K.; Pessoa, C.; Odorico de Moraes, M.; Lotufo, L.V.; Magalhaes, H.I.F.; Carvalho, Nadia, C.P. Chemical constituents of Parmotrema lichexanthonicum Eliasaro & Adler - isolation, structure modification and evaluation of antibiotic and cytotoxic activities. Quim. Nova, 2009, 32(1), 12-20.
42. Millot, M.; Tomasi, S.; Studzinska, E.; Rouaud, I.; Boustie, J. Cytotoxic constituents of the lichen Diploicia canescens. J. Nat. Prod., 2009, 72(12), 2177-2180.
43. Neamati, N.; Hong, H.; Mazumder, A.; Wang, S.; Sunder, S.; Nicklaus, M.C. George W.A.M.; Proksa, B.; Pommier, Y. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J. Med.Chem., 1997, 40, 942-951.
44. Gissurarson, S.; Sigurdsson, S.; Wagner, H.; Ingolfsdottir, K. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig Taenia coli. J. Pharmacol. Exp. Ther., 1997, 280, 770-773.
45. Ingolfsdottir, K.; Gissurarson, S.R.; Muller-Jakic, B.; Breu, W.; Wagner, H. Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro. Phytomedicine, 1996, 2(3), 243-246.
46. Seo, C.; Sohn, J.H.; Ahn, J.S.; Yim, J.H.; Lee, H.K.; Oh, H. Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the Antarctic lichen Stereocaulon alpinum. Bioorg. Med. Chem. Lett., 2009, 19, 2801-2803.
47. Fournet, A.; Ferreira, M.E.; Rojas de Arias, A.; Torres de Ortiz, S.; Inchausti, A.; Yaluff, G.; Quilhot, W.; Fernandez, E.; Hidalgo, M.E. Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis. Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol., 1997, 116(1), 51-54.
48. Ingolfsdottir, K.; Chung, G.A.; Skulason, V.G.; Gissurarson, S.R; Vilhelmsdóttir, M. Antimycobacterial activity of lichen metabolites in vitro. Eur. J. Pharm. Sci., 1998, 6, 141-144.
49. Ivanova, V.; Aleksieva, K.; Kolarova, M.; Chipeva, V.; Schlegel, R.; Schlegel, B.; Gräfe, U. Neuropogonines A, B and C, new depsidon-type metabolites from Neuropogon sp., an antarctic lichen. Pharmazie, 2002, 57, 73-74.
50. Rankoviš, B.; Mišiš, M.; Sukdolak, S. The antimicrobial activity of substances derived from the lichens Physcia aipolia, Umbilicaria polyphylla, Parmelia caperata and Hypogymnia physodes. World J. Microbiol. Biotechnol., 2008, 24, 1239-1242.
51. Rankoviš, B.; Mišiš, M. The antimicrobial activity of the lichen substances of the lichens Cladonia furcata, Ochrolechia androgyna, Parmelia caperata and Parmelia conspersa. Biotechnol. Biotechnol. Equip., 2008, 22, 1013-1016.
52. Fernandez, E.; Reyes, A.; Hidalgo, M.E.; Quilhot, W. Photoprotector capacity of lichen metabolites assessed through the inhibition of the 8- methoxypsoralen photobinding to protein. J. Photochem. Photobiol. B, 1998, 42, 195-201.
53. Rancan, F.; Rosan, S.; Boehm, K.; Fernández, E.; Hidalgo, M.E.; Quihot, W.; Rubio, C.; Boehm, F.; Piazena, H.; Oltmanns, U. Protection against UVB irradiation by natural filters extracted from lichens. J. Photochem. Photobiol. B, 2002, 68, 133-139.
54. Thune, P.; Solberg, Y.J. Photosensitivity and allergy to aromatic lichen acids, Compositae oleoresins and other plant substances. Contact Dermatitis, 1980, 6, 81-87.